Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Onancock › NPI 1619076916
Hospital

Shore Health Services INC.

Shore Health Services INC. was paid $24.72M by Medicaid between Jan 2018 and Dec 2024, across 265 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.

33Billing provider infoSHORE HEALTH SERVICES INC.
ONANCOCK, VA 23417
33aNPI1619076916assigned 09/22/2006
33bProvider typeRural Acute Care Hospital
28Total paid$24.72M
24GClaims724,116
24DCodes billed265
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rural Acute Care Hospital providers in Virginia

Rank by total paid#2 of 6
Median peer was paid$20.60M
This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official AUSTIN, WALTER controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201876,615$1.66M
2019101,355$2.72M
202092,031$2.94M
2021112,950$3.81M
2022107,292$3.63M
2023134,053$5.31M
2024incomplete99,820$4.64M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 22% 33,472 28,789 $5.46M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 25,048 20,565 $3.73M
96361 Intravenous infusion, hydration; each additional hour 11% 12,004 8,143 $2.62M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 9.1% 32,291 23,757 $2.25M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.6% 10,020 7,164 $1.62M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.8% 4,287 3,621 $690K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.3% 2,398 2,091 $575K
70450 Computed tomography, head or brain; without contrast material 2.3% 4,383 3,606 $569K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 11,765 3,143 $491K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 1.8% 4,620 3,592 $457K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.5% 3,816 3,000 $371K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 6,275 4,378 $361K
253 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.5% 2,364 $360K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.2% 2,534 $297K
G0378 Hospital observation service, per hour 1.1% 2,415 $271K
59025 Fetal non-stress test 1.0% 1,824 $256K
20610 <1% 1,929 $234K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,569 $227K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 419 $208K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,473 $203K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,032 $175K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 306 $175K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,379 $162K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,426 $153K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 425 $133K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 676 $131K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,444 $119K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,356 $115K
71275 Computed tomographic angiography, chest, with contrast material <1% 560 $102K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 5,561 $100K
77067 Screening mammography, bilateral, including computer-aided detection <1% 3,615 $99K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,023 $92K
93017 <1% 981 $91K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,885 $90K
80053 Comprehensive metabolic panel <1% 24,734 $84K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,022 $81K
11056 <1% 1,429 $79K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 159 $71K
97162 <1% 595 $69K
76642 <1% 589 $64K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,623 $60K
96367 <1% 1,092 $55K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,500 $54K
71046 Radiologic examination, chest; 2 views <1% 5,178 $48K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,423 $48K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 310 $40K
72125 Computed tomography, cervical spine; without contrast material <1% 1,399 $37K
93971 <1% 459 $37K
70551 Magnetic resonance imaging, brain; without contrast material <1% 215 $35K
87040 <1% 6,136 $32K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 10,477 $29K
73560 <1% 1,952 $28K
94060 <1% 516 $28K
10060 <1% 385 $28K
71250 <1% 453 $27K
80048 Basic metabolic panel (calcium, ionized) <1% 10,452 $25K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,915 $25K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 36,665 $24K
71271 <1% 223 $22K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 123 $22K
83880 <1% 2,746 $19K
73630 <1% 1,602 $19K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 27 $19K
73030 <1% 1,678 $18K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 102 $18K
73610 <1% 1,394 $18K
90715 <1% 1,075 $17K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 204 $15K
71045 Radiologic examination, chest; single view <1% 12,977 $15K
84443 Thyroid stimulating hormone (TSH) <1% 3,107 $13K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,426 $12K
94729 <1% 433 $12K
94618 <1% 177 $12K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,493 $11K
73110 <1% 682 $11K
76830 Ultrasound, transvaginal <1% 106 $10K
97163 <1% 74 $10K
80076 <1% 3,601 $10K
84484 <1% 12,303 $10K
36415 Collection of venous blood by venipuncture <1% 15,249 $10K
80047 <1% 3,370 $10K
94726 <1% 345 $10K
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units <1% 188 $9K
J3490 Unclassified drugs <1% 15,758 $9K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 13 $9K
96375 Therapeutic injection; each additional sequential IV push <1% 10,344 $8K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 560 $7K
93325 <1% 57 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 8,428 $7K
97161 <1% 430 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 4,321 $6K
74018 <1% 432 $6K
73502 <1% 586 $6K
73130 <1% 645 $6K
76536 <1% 56 $6K
83735 <1% 11,315 $6K
87077 <1% 3,662 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,841 $5K
86885 <1% 2,613 $5K
86756 <1% 411 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,990 $5K
80061 Lipid panel <1% 2,308 $4K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,508 $4K
83605 <1% 4,403 $4K
85379 <1% 873 $4K
93350 <1% 13 $4K
76775 <1% 43 $4K
81025 <1% 7,357 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,482 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 568 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 2,764 $4K
77065 Tomosynthesis, mammo <1% 79 $4K
70498 <1% 13 $4K
A9150 Non-prescription drugs <1% 42,392 $3K
81002 <1% 8,175 $3K
J2469 Injection, palonosetron hcl, 25 mcg <1% 170 $3K
96415 <1% 21 $3K
12001 <1% 16 $3K
81003 <1% 2,452 $3K
82728 <1% 1,841 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 15 $3K
77336 <1% 43 $3K
86900 <1% 2,869 $3K
85027 <1% 1,314 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,149 $3K
70486 <1% 45 $2K
J2704 Injection, propofol, 10 mg <1% 7,512 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,443 $2K
G0127 Trimming of dystrophic nails, any number <1% 549 $2K
81001 <1% 16,824 $2K
82947 <1% 8,155 $2K
77066 Tomosynthesis, mammo <1% 44 $2K
93880 <1% 33 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 10,488 $2K
87081 <1% 2,646 $2K
86901 <1% 2,869 $2K
83550 <1% 1,694 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,371 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 68 $2K
86140 <1% 1,069 $2K
11721 <1% 534 $1K
87430 <1% 2,716 $1K
83540 <1% 1,719 $1K
84702 <1% 648 $1K
85610 <1% 3,513 $1K
72100 <1% 95 $1K
80069 <1% 702 $1K
87186 <1% 3,822 $1K
74220 <1% 28 $1K
84439 <1% 642 $960.42
82565 <1% 1,809 $918.73
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 1,277 $881.88
73562 <1% 261 $879.09
73140 <1% 120 $855.61
83970 <1% 192 $837.88
11057 <1% 20 $824.46
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,811 $816.68
0100U <1% 69 $728.05
73080 <1% 59 $715.77
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,599 $704.37
Q3014 Telehealth originating site facility fee <1% 111 $703.38
80143 <1% 142 $681.75
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,946 $665.28
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 217 $651.21
80164 <1% 136 $616.03
82570 <1% 781 $607.63
87340 <1% 229 $581.07
82607 <1% 270 $577.94
87653 <1% 12 $549.06
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 47 $521.41
85652 <1% 819 $498.40
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 666 $498.24
83690 <1% 6,538 $486.18
73590 <1% 65 $481.14
85730 <1% 1,156 $448.48
87070 <1% 516 $419.90
80179 <1% 134 $407.94
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 753 $385.67
85014 <1% 3,626 $372.55
86592 <1% 190 $362.14
90686 <1% 50 $335.43
96417 <1% 19 $333.27
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,083 $331.91
A9585 Injection, gadobutrol, 0.1 ml <1% 1,818 $312.58
87205 <1% 820 $278.41
73565 <1% 33 $262.70
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 43 $255.78
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,668 $254.04
J1815 Injection, insulin, per 5 units <1% 698 $223.95
J2550 Injection, promethazine hcl, up to 50 mg <1% 208 $215.95
84156 <1% 541 $209.08
J1040 Injection, methylprednisolone acetate, 80 mg <1% 1,823 $159.52
82077 <1% 1,710 $158.84
J0690 Injection, cefazolin sodium, 500 mg <1% 607 $131.35
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,749 $127.89
51798 <1% 27 $125.68
84550 <1% 241 $117.21
84703 <1% 1,308 $110.56
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,218 $109.41
87210 <1% 236 $108.96
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 2,310 $95.04
82270 <1% 361 $82.84
84153 <1% 13 $76.30
74022 <1% 42 $74.56
83615 <1% 164 $73.66
86803 <1% 27 $67.79
J2060 Injection, lorazepam, 2 mg <1% 966 $66.87
84100 <1% 76 $57.40
A4351 Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each <1% 1,160 $56.41
J1030 Injection, methylprednisolone acetate, 40 mg <1% 23 $55.77
96376 <1% 2,535 $54.03
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 1,500 $51.82
82248 <1% 117 $51.62
00811 <1% 31 $51.19
J1756 Injection, iron sucrose, 1 mg <1% 145 $47.39
36592 <1% 107 $44.29
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,476 $43.54
99152 <1% 38 $25.74
88342 <1% 59 $17.14
82550 <1% 74 $15.89
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 921 $15.79
J1010 Injection, methylprednisolone acetate, 1 mg <1% 256 $14.32
82803 <1% 250 $14.23
J3480 Injection, potassium chloride, per 2 meq <1% 268 $13.20
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 712 $12.15
99153 Mod sedat endo service >5yrs <1% 49 $12.14
J0780 Injection, prochlorperazine, up to 10 mg <1% 120 $8.76
J3370 Injection, vancomycin hcl, 500 mg <1% 190 $4.49
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 58 $3.67
J1170 Injection, hydromorphone, up to 4 mg <1% 61 $3.03
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 29 $2.74
J1940 Injection, furosemide, up to 20 mg <1% 49 $1.09
82533 <1% 15 $0.31
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 191 $0.11
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 2,867 $0.02
J1596 Injection, glycopyrrolate, 0.1 mg 0% 162 $0.00
00731 0% 159 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 54 $0.00
J8499 Prescription drug, oral, non chemotherapeutic, nos 0% 64 $0.00
00812 0% 164 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 62 $0.00
51701 0% 16 $0.00
84295 0% 14 $0.00
94664 0% 48 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 35 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 37 $0.00
A6403 Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing 0% 38 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 27 $0.00
A9270 Non-covered item or service 0% 9,140 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 172 $0.00
G0008 Administration of influenza virus vaccine 0% 66 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 118 $0.00
96368 0% 85 $0.00
84132 0% 16 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 100 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 72 $0.00
V2632 Posterior chamber intraocular lens 0% 42 $0.00
71101 0% 14 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 29 $0.00
00142 0% 43 $0.00
70496 0% 13 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 16 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 16 $0.00
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 0% 32 $0.00
86762 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAUSTIN, WALTER (CFO)
Same official

Other billing entities under AUSTIN, WALTER

Full network →
ProviderLocationPaid
Riverside Hospital INCNewport News, VA$136.80M
Riverside Middle Peninsula Hospital INCGloucester, VA$19.02M
Doctors' Hospital of WilliamsburgWilliamsburg, VA$11.99M
Riverside Hospital INCNewport News, VA$4.48M
Patrick Henry Hospital, INC.Newport News, VA$1.52M
Shore Health Services, INCAccomac, VA$1.31M
Riverside Hospice and Homecare Services LLCWarsaw, VA$438K
Riverside Hospital INCNewport News, VA$412K
Riverside Middle Peninsula Hospital INCGloucester, VA$37K
Riverside Hospital, INCNewport News, VA$6K
Patrick Henry Hospital, INC.West Point, VA$4K
Shore Health Services INCAccomac, VA$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.